Product development

At Genomill Health, our vision is to make genetic testing a standard clinical practice. Genetic testing is developing rapidly and is already affecting clinical procedures. For instance, liquid biopsies are permitting non-invasive cancer diagnostics, and affordable genome sequencing is permitting tailored medication for diverse conditions from cardiological problems to depression.

However, broad adoption of genetically informed medicine is currently slowed down by high test prices and long turn-around times Our mission is to change this by creatively tapping into the analytical potential of next-generation DNA sequencing.